Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.

[1]  J. van Rosmalen,et al.  Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study). , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  E. Eden,et al.  Validation of a Novel Assay to Distinguish Bacterial and Viral Infections , 2017, Pediatrics.

[3]  J. D. de Groot,et al.  A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. , 2017, The Lancet. Infectious diseases.

[4]  Alan E. Jones,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[5]  E. V. van Gorp,et al.  TRAIL and IP-10 as biomarkers of viral infections in the emergency department. , 2016, The Journal of infection.

[6]  J. van Rosmalen,et al.  Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study , 2016, BMC Emergency Medicine.

[7]  Yaniv Dotan,et al.  A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections , 2015, PloS one.

[8]  A. Gervaix,et al.  C-reactive Protein, Procalcitonin and the Lab-Score for Detecting Serious Bacterial Infections in Febrile Children at the Emergency Department: A Prospective Observational Study , 2014, The Pediatric infectious disease journal.

[9]  H. Goossens,et al.  Antibiotic resistance—the need for global solutions , 2013, BDJ.

[10]  T. Bregenzer,et al.  Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. , 2009, JAMA.

[11]  S. Levy,et al.  Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.

[12]  E. Alpern,et al.  Epidemiology of a Pediatric Emergency Medicine Research Network: The PECARN Core Data Project , 2006, Pediatric emergency care.

[13]  M. Christ-Crain,et al.  Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.

[14]  M. Christ-Crain,et al.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.

[15]  O. Cars,et al.  The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe , 2002, Emerging Infectious Diseases.